Phase II Study of Short Hydration without Diuretics for Cisplatin-Based Chemotherapy
Short hydration without diuretics is safe for patients receiving cisplatin-containing chemotherapy. Randomized trials with or without diuretics in this setting are warranted.
Authors
- Takehiro Tozuka (ORCID: https://orcid.org/0000-0002-3774-8915)
- Rei Yamaguchi (ORCID: https://orcid.org/0000-0002-8669-3113)
- Tetsuya Wako
- Ryosuke Arakawa (ORCID: https://orcid.org/0000-0001-5569-1361)
- Shinji Nakamichi (ORCID: https://orcid.org/0000-0002-2298-6945)
- Masahiro Seike (ORCID: https://orcid.org/0000-0002-1572-5472)
- Naomi Onda
- Akihiko Miyanaga (ORCID: https://orcid.org/0000-0003-2026-9181)
- Tomoyasu Inoue
- Yasuhiro Kato (ORCID: https://orcid.org/0000-0001-8585-1995)
- Kaoru Kubota (ORCID: https://orcid.org/0000-0003-0367-2606)
- Masaru Matsumoto (ORCID: https://orcid.org/0000-0001-6647-6624)
- Kaoruko Shimbu
- Junichi Aoyama
Institutions
- Nippon Medical School Hospital (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Journal of Nippon Medical School
- Published
- 2025-04-20
- DOI
- https://doi.org/10.1272/jnms.jnms.2025_92-210
- Primary Topic
- Chemotherapy-induced organ toxicity mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00